T2D
Clinical trials for T2D explained in plain language.
Never miss a new study
Get alerted when new T2D trials appear
Sign up with your email to follow new studies for T2D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug protect kidneys in obesity? new trial investigates
Disease control OngoingThis Phase 2 trial tests whether tirzepatide, a drug already used for diabetes and weight loss, can improve kidney health in 140 people with obesity and chronic kidney disease (with or without type 2 diabetes). Researchers will use MRI scans to measure changes in kidney fat and b…
Matched conditions: T2D
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Hidden liver risk in diabetes patients revealed
Knowledge-focused OngoingThis study aims to find out how many people with type 2 diabetes also have non-alcoholic fatty liver disease (NAFLD). Researchers will use a special ultrasound scan (FibroScan) to check the liver health of 385 adults with type 2 diabetes. The study does not test any new treatment…
Matched conditions: T2D
Phase: NA • Sponsor: Ziekenhuis Oost-Limburg • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC